Filing identity and reporting period
Important discrepancy: The supplied filing is Nanometrics Incorporated’s Form 10-K for the fiscal year ended December 28, 2013, filed March 7, 2014. It is not an ONTO Innovation filing or a 2011 Q4 report. The summary below reflects the filing provided.
Nanometrics designed and sold metrology and inspection systems primarily for semiconductor manufacturing, with additional exposure to LEDs, solar photovoltaics, data storage and related markets. Its fiscal years 2013 and 2012 each contained 52 weeks.
Financial performance and position
| Metric | FY 2013 | FY 2012 |
|---|---|---|
| Revenue | $144.3 million | $182.9 million |
| Gross profit / gross margin | $62.7 million / 43.4% | $83.9 million / 45.9% |
| Operating income (loss) | $(21.7) million | $5.5 million |
| Net income (loss) | $(14.1) million; $(0.61) per diluted share | $4.5 million; $0.19 per diluted share |
| Cash from operating activities | $(2.4) million | $24.0 million |
| Cash, cash equivalents and marketable securities | $92.9 million | $109.9 million |
| Working capital | $141.8 million | $158.6 million |
| Debt at year-end | None | $5.3 million |
- Product revenue declined 25.3% to $107.4 million; service revenue decreased 5.5% to $36.9 million. Automated systems accounted for most of the product decline.
- Product gross margin was 44.6%, down from 47.2%; service gross margin was 47.2%, nearly flat year over year.
- Investing activities used $7.8 million, including $5.7 million of capital expenditures. Financing activities used $7.5 million, including $5.0 million of share repurchases and repayment of the remaining $4.8 million mortgage balance.
- The company had no borrowings on its revolving credit line. The reported borrowing base was $12.3 million, subject to facility terms.
- Q4 FY 2013 unaudited revenue was $46.2 million, operating income $1.3 million and net income $0.6 million, versus Q3 revenue of $39.0 million and a $4.6 million net loss.
Changes versus comparable periods
- Full-year revenue fell 21.1%, primarily reflecting lower customer demand associated with an industry-wide slowdown in memory-related semiconductor capital spending.
- Operating performance moved from $5.5 million of operating income in 2012 to a $21.7 million operating loss in 2013. Lower revenue and gross margin coincided with higher operating expenses, including increased R&D investment and a restructuring charge.
- Operating cash flow swung from positive $24.0 million to negative $2.4 million. Working-capital use included increases in receivables and inventory; deferred revenue and accounts payable partially offset those uses.
- Cash and marketable securities declined $17.0 million year over year. The company also eliminated its mortgage debt through repayment in July 2013.
- Q4 revenue improved sequentially from Q3 and was above Q4 2012 revenue of $30.3 million; however, the filing does not establish that the sequential improvement represents a sustained recovery.
Outlook, commentary, risks and unusual items
- Management stated that existing cash, marketable securities, borrowing availability and projected operating cash generation should meet liquidity needs for at least the next 12 months. No quantified revenue or earnings guidance was provided.
- Management highlighted demand drivers including more complex semiconductor processes, broader optical critical-dimension metrology adoption, advanced packaging and new materials. It continued investing in products and platforms, including Atlas, IMPULSE, UniFire and SPARK initiatives.
- A $1.7 million restructuring charge was recorded in 2013 to consolidate part of European operations; the filing expected approximately $0.2 million of additional charges through May 2014. Related severance cash payments had been made by year-end.
- The $9.4 million income-tax benefit reduced the reported net loss; it included benefits associated with the reinstated federal R&D tax credit. This benefit should be distinguished from operating performance and cash generation.
- Other expense included a $1.3 million increase in the fair value of contingent Zygo payments and foreign-exchange losses. The company reported $2.8 million of Zygo-related contingent liabilities and $25.1 million of inventory purchase commitments.
- Key risks include semiconductor-industry cyclicality, substantial customer concentration (three customers represented 62.9% of revenue), reliance on limited-source suppliers, order cancellations or shipment deferrals, international and foreign-exchange exposure, competition, product acceptance and intellectual-property claims.
- The company reported no off-balance-sheet arrangements, no pending legal proceedings in the filing’s legal-proceedings section, and no 2013 goodwill or long-lived-asset impairment. Management and the auditor reported effective internal control over financial reporting; the auditor issued an unqualified opinion on the financial statements.
Important facts for investors to verify
- Confirm the issuer and reporting period: this is Nanometrics FY 2013, not ONTO Innovation or 2011 Q4.
- Assess whether the Q4 sequential revenue and profit improvement continued after year-end, given full-year losses and semiconductor-cycle exposure.
- Review customer concentration and memory-capital-spending trends, particularly the impact of major customers on orders and collections.
- Examine inventory levels, write-downs and operating cash conversion; the filing reported $7.6 million of inventory write-downs and negative operating cash flow.
- Separate the tax benefit from recurring operating results and review the assumptions behind deferred tax assets and valuation allowances.
- Check the timing and terms of Zygo-related payments, supplier commitments and the stated available credit capacity.